Enovis Set to Maintain Double-Digit Recon Growth in 2024 Company Revenue The Numbers The company's orthopedic sales grew in the mid-teens for 2023 and is likely to be a $1 billion recon player in 2024. Feb 26, 2024
Globus Aims For Integration Steady State by Mid-2024 Company Revenue The Numbers The company finished 2023 with reported sales growth over 50% as it works to integrate NuVasive and reach a steady state in June 2024. Feb 22, 2024
Joint Replacement Makes Up For Lost Time in 2023 Chart of the Month The Numbers Backlogged procedures drove much of the robust demand for joint replacement in 2023 but more durable tailwinds could also be taking hold. Feb 16, 2024
Zimmer Biomet Officially Enters Growth Era Company Revenue The Numbers Healthy end markets and a robust innovation pipeline drove mid-single-digit growth for the company in 2023. Feb 09, 2024
Orthopedic Funding Slows, Focuses on Digital Investments The Numbers While economic pressure slowed orthopedic funding in recent years, there is ample capital for enabling technology companies. Feb 06, 2024
CONMED’s Ortho Offense Handcuffed by Supply Issues Company Revenue The Numbers The company grew in the mid-teens for 2023 but can't fully go on offense until it resolves its supply chain issues. Feb 02, 2024
Stryker Remains Gold Standard Among Ortho Peers Company Revenue The Numbers The company's orthopedic sales grew nearly 10% in 2023, driven by strong procedure demand, leadership in robotics and momentum in trauma. Feb 01, 2024
DePuy Synthes Climbs Back to Pre-Pandemic Levels Company Revenue The Numbers The company grew in the mid-single-digits in 2023 as new products and recovering markets fueled its rebound to pre-COVID levels. Jan 24, 2024
Burning Questions for the Top Orthopedic Players in 2024 Market Analysis The Numbers Public orthopedic companies with over $2 billion in annual sales control more than 60% of the market, but face questions in 2024. Jan 17, 2024
Spine-Related M&A Rebounds After Weak 2022 Chart of the Month The Numbers We expect around 30 orthopedic M&A transactions in 2024 with activity remaining focused on spine-related assets. Jan 10, 2024